Meeting
2023 ASCO Annual Meeting
Examining clinical trial eligibility for oncology patients with human immunodeficiency virus (HIV): A global cross-sectional analysis.
Authors
Umar Abdullahi
The Christie NHS Foundation Trust, Manchester, United Kingdom
Umar Abdullahi , Sammy Shaya , Habana Dinizulu , Emily Sampey , David Appleton , Matthew Concannon , Donna M. Graham
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Health Services Research and Quality Improvement
Track
Quality Care/Health Services Research
Sub Track
Access to Care
Citation
J Clin Oncol 41, 2023 (suppl 16; abstr 6554)
DOI
10.1200/JCO.2023.41.16_suppl.6554
Abstract #
6554
Poster Bd #
46
Abstract Disclosures
Similar Posters
Poster
2021 ASCO Quality Care Symposium
Improving hematology/oncology clinical research recruitment via universal prescreening: The VA Connecticut (VACT) Cancer Center experience.
First Author: Jenny Jing Xiang
Poster
2020 ASCO Virtual Scientific Program
Outcomes of patients with metastatic renal cell carcinoma (mRCC) treated with first-line Immuno-oncology (IO) agents who do not meet eligibility criteria for clinical trials.
First Author: Chun Loo Gan
Poster
2024 ASCO Annual Meeting
The impact of HIV and CD4 count stratification on all cause mortality for adenocarcinoma and squamous cell lung cancers in the antiretroviral therapy era: Analysis of National Veterans Affairs and Kaiser Permanente Northern cohorts.
First Author: Elizabeth Y. Chiao
Poster
2024 ASCO Genitourinary Cancers Symposium
UNICAB: Cabozantinib in locally advanced or metastatic non‐clear cell renal cell carcinoma post immunotherapy or in those unsuitable for immunotherapy (ANZUP 1802).
First Author: David William Pook